U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions Guidance for Industry December 2016

Download the Final Guidance Document
Final
Docket Number:
FDA-2011-D-0147
Issued by:
Guidance Issuing Office
Center for Tobacco Products

This guidance provides information in response to frequently asked questions (FAQs) that the Center for Tobacco Products (CTP) has received from manufacturers and other interested stakeholders on demonstrating the substantial equivalence (SE) of a new tobacco product. Among other things, this guidance includes information on FDA’s current thinking on whether a change to the product quantity in the package renders a product “new” and thus subject to premarket review.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2011-D-0147.

Questions?

Back to Top